USD 0.05
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 14.8 Million USD | 3.15% |
2022 | 14.35 Million USD | -9.55% |
2021 | 15.86 Million USD | 107.59% |
2020 | 7.64 Million USD | 23.01% |
2019 | 6.21 Million USD | 621.72% |
2018 | 860.99 Thousand USD | 82.09% |
2017 | 472.85 Thousand USD | 31.19% |
2016 | 360.42 Thousand USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 14.74 Million USD | -0.43% |
2024 Q2 | 15.6 Million USD | 5.85% |
2023 FY | 14.8 Million USD | 3.15% |
2023 Q3 | 14.75 Million USD | 1.8% |
2023 Q2 | 14.49 Million USD | 0.66% |
2023 Q1 | 14.39 Million USD | 0.32% |
2023 Q4 | 14.8 Million USD | 0.34% |
2022 Q3 | 14.35 Million USD | 0.13% |
2022 Q4 | 14.35 Million USD | 0.01% |
2022 FY | 14.35 Million USD | -9.55% |
2022 Q1 | 14.3 Million USD | -9.88% |
2022 Q2 | 14.33 Million USD | 0.23% |
2021 Q3 | 11.78 Million USD | 1.51% |
2021 Q2 | 11.6 Million USD | 21.86% |
2021 FY | 15.86 Million USD | 107.59% |
2021 Q4 | 15.86 Million USD | 34.7% |
2021 Q1 | 9.52 Million USD | 24.58% |
2020 Q3 | 8.26 Million USD | 43.46% |
2020 Q1 | 6.78 Million USD | 9.12% |
2020 FY | 7.64 Million USD | 23.01% |
2020 Q2 | 5.76 Million USD | -15.04% |
2020 Q4 | 7.64 Million USD | -7.51% |
2019 FY | 6.21 Million USD | 621.72% |
2019 Q2 | 2.57 Million USD | -4.93% |
2019 Q4 | 6.21 Million USD | 90.92% |
2019 Q3 | 3.25 Million USD | 26.47% |
2019 Q1 | 2.7 Million USD | 214.39% |
2018 Q2 | 1.04 Million USD | -3.77% |
2018 FY | 860.99 Thousand USD | 82.09% |
2018 Q4 | 860.99 Thousand USD | 49.96% |
2018 Q3 | 574.16 Thousand USD | -45.25% |
2018 Q1 | 1.08 Million USD | 130.45% |
2017 Q3 | 308.74 Thousand USD | 22.53% |
2017 Q4 | 472.85 Thousand USD | 53.15% |
2017 Q2 | 251.97 Thousand USD | -44.29% |
2017 Q1 | 452.26 Thousand USD | 43.1% |
2017 FY | 472.85 Thousand USD | 31.19% |
2016 Q4 | 316.05 Thousand USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | 360.42 Thousand USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q2 | - USD | -100.0% |
2013 Q1 | 2751.98 USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.51 Billion USD | 99.02% |
Addus HomeCare Corporation | 175.18 Million USD | 91.549% |
AirSculpt Technologies, Inc. | 99.66 Million USD | 85.146% |
Amedisys, Inc. | 487.21 Million USD | 96.961% |
American Oncology Network, Inc. | 128.32 Million USD | 88.463% |
Astrana Health, Inc. | 321.01 Million USD | 95.388% |
Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 99.012% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 114.87 Million USD | 87.112% |
Cryo-Cell International, Inc. | 10.89 Million USD | -35.875% |
Cross Country Healthcare, Inc. | 5.26 Million USD | -181.09% |
COMPASS Pathways plc | 33.04 Million USD | 55.204% |
DocGo Inc. | 46.49 Million USD | 68.159% |
The Ensign Group, Inc. | 1.87 Billion USD | 99.209% |
Healthcare Services Group, Inc. | 43.63 Million USD | 66.071% |
InnovAge Holding Corp. | 113.03 Million USD | 86.902% |
The Joint Corp. | 16.73 Million USD | 11.532% |
LifeStance Health Group, Inc. | 511.04 Million USD | 97.103% |
Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -2152.969% |
ModivCare Inc. | 1.14 Billion USD | 98.701% |
NewGenIvf Group Limited | 332.55 Thousand USD | -4351.922% |
Novo Integrated Sciences, Inc. | 4.47 Million USD | -231.086% |
Option Care Health, Inc. | 1.16 Billion USD | 98.731% |
P3 Health Partners Inc. | 124.64 Million USD | 88.122% |
P3 Health Partners Inc. | 124.64 Million USD | 88.122% |
The Pennant Group, Inc. | 329.63 Million USD | 95.509% |
Surgery Partners, Inc. | 3.06 Billion USD | 99.516% |
Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -5867.28% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 119.81 Million USD | 87.643% |
The Oncology Institute, Inc. | 119.81 Million USD | 87.643% |